99 related articles for article (PubMed ID: 3513537)
1. Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemia.
Lazzarino M; Morra E; Brusamolino E; Inverardi D; Castelli G; Merante S; Bernasconi C
Am J Clin Oncol; 1986 Feb; 9(1):45-9. PubMed ID: 3513537
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H;
Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
[TBL] [Abstract][Full Text] [Related]
3. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
Koller CA; Miller DM
N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313
[TBL] [Abstract][Full Text] [Related]
4. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
[TBL] [Abstract][Full Text] [Related]
5. The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
Antimi M; Masi M; Delannoy A; Ferrant A; Doyen C; Debusscher L; Delwiche F; Stryckmans P; Papa G
Haematologica; 1990; 75(5):443-6. PubMed ID: 2151448
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.
Schwartz JH; Cannellos GP
Blood; 1975 Jul; 46(1):11-6. PubMed ID: 1055610
[TBL] [Abstract][Full Text] [Related]
7. Therapy of the blast phase of chronic granulocytic leukemia with mithramycin and hydroxyurea.
Queisser W; Herrmann F; Lindemann A; Anger B; Hiddemann W; Krey U
Onkologie; 1988 Jun; 11(3):145-6. PubMed ID: 2970612
[No Abstract] [Full Text] [Related]
8. Characterization and treatment of the non-lymphoblastic crisis of chronic myelogenous leukemia.
Mariani G; Annino L; Solinas S; Mandelli F
Tumori; 1983 Dec; 69(6):521-6. PubMed ID: 6582679
[TBL] [Abstract][Full Text] [Related]
9. Meningeal leukaemia in the blastic phase of chronic granulocytic leukaemia.
Van Bever H; Benoit Y; Delbeke MJ; Orye E
Eur J Pediatr; 1985 Nov; 144(4):417-8. PubMed ID: 3865773
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with interferon alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemia.
Bourantas KL; Syrou M; Tsiara S; Danella M; Konstantinides P
Acta Haematol; 1996; 95(2):117-21. PubMed ID: 8638440
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for chronic granulocytic leukaemia.
Allan NC; Duvall E; Stockdill G
Lancet; 1978 Sep; 2(8088):523. PubMed ID: 79887
[No Abstract] [Full Text] [Related]
12. Hydroxyurea potentiation of the antineoplastic activity of cyclophosphamide and 4'-(9-acridinylamino)methanesulfon-M-anisidide (AMSA) in the brown Norway rat myelocytic leukemia model.
Vaughan WP; Holm C; Cordel K
Cancer Chemother Pharmacol; 1989; 23(1):26-30. PubMed ID: 2909287
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studies.
Coleman M; Silver RT; Pajak TF; Cavalli F; Rai KR; Kostinas JE; Glidewell O; Holland JF
Blood; 1980 Jan; 55(1):29-36. PubMed ID: 6927956
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of hydroxyurea cytotoxicity by sintamil in human chronic myeloid leukemia cells.
Pradhan SG; Chitnis MP; Basrur VS; Satyamoorthy K; Advani SH
Tumori; 1986 Oct; 72(5):507-10. PubMed ID: 3467512
[TBL] [Abstract][Full Text] [Related]
15. Failure of mithramycin to control the myeloid blast phase of chronic granulocytic leukemia: a report on nine patients and review of the literature.
Johnson PR; Yin JA; Narayanan MN; Geary CG; Love EM; Cinkotai KI
Hematol Oncol; 1991; 9(1):9-15. PubMed ID: 1828453
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of hydroxyurea cytotoxicity in human chronic myeloid leukemia cells by iron-chelating agent.
Satyamoorthy K; Chitnis MP; Basrur VS; Advani SH
Leuk Res; 1986; 10(11):1327-30. PubMed ID: 3099095
[TBL] [Abstract][Full Text] [Related]
17. A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Kühr T; Burgstaller S; Apfelbeck U; Linkesch W; Seewann H; Fridrik M; Michlmayr G; Krieger O; Lutz D; Lin W; Pont J; Köck L; Abbrederis K; Baldinger C; Buder R; Geissler D; Hausmaninger H; Lang A; Zabernigg A; Duba C; Hilbe W; Eisterer W; Fiegl M; Greil R; Gastl G; Thaler J;
Leuk Res; 2003 May; 27(5):405-11. PubMed ID: 12620292
[TBL] [Abstract][Full Text] [Related]
18. [A case of granulocytic sarcoma preceding acute nonlymphocytic leukemia].
Morioka E; Hisano S; Ishibashi M; Kawara T; Kyoushouin K; Kimura N; Okumura M
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):840-1. PubMed ID: 2794666
[No Abstract] [Full Text] [Related]
19. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Anger B; Porzsolt F; Leichtle R; Heinze B; Bartram C; Heimpel H
Blut; 1989 Jun; 58(6):275-8. PubMed ID: 2736308
[TBL] [Abstract][Full Text] [Related]
20. Meningeal leukemia in the blastic phase of chronic granulocytic leukemia.
Schwartz JH; Canellos GP; Young RC; DeVita VT
Am J Med; 1975 Dec; 59(6):819-28. PubMed ID: 1059328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
